HEALTHCARE 2020 - 6-Hour Virtual Seminar on Tougher Import Rules for FDA Imports in 2020

Website https://www.globalcompliancepanel.com/virtual-seminar/-10389LIVE?channel=ourglocal-march_2020_SEO | Edit Freely

Category HEALTHCARE 2020

Deadline: March 02, 2020 | Date: March 02, 2020

Venue/Country: Online Event, U.S.A

Updated: 2020-01-17 21:19:38 (GMT+9)

Call For Papers - CFP

Likewise, the U.S. Customs and Border Protection (CBP) must be precise or your entry is not going anywhere. Some mistakes are common, others reflect a lack of understanding of how FDA and Customs and Border Protection (CBP) operate a joint program.

The logistics of importing products complicates the process further and you must know the consequences of your decisions. Some problems can cost you time and money, especially when you do not work promptly with the FDA. If you end up with having your entry "refused." There is no appeal. Then you face the possibility of additional steep fines by CBP and be blocked from the U.S. market.

Why you should attend

Firms typically run aground with importing FDA regulated products because they do not understand how to prepare, conduct and report information in accord with FDA requirements. That mire of activity starts before you even ship a product to the U.S. If the exporter and importer do not follow the procedures or fail to submit correct information, the road forward has an expensive and time-consuming toll.

A failure to do things correctly will create a "bad actor" image, which is very hard to undo and FDA does not forget, somewhat like a regulatory elephant. It is true. If you understand FDA's and CBP's import program, your business can operate in a competitive way. If you do not, your customers, foreign suppliers, and stockholders will see the consequences and not be forgiving.

Who Will Benefit

Regulatory Affairs Directors

Software Designers / Specification Developers

Production Managers

Quality Assurance Directors

In-house Legal Counsel